Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CLIAC workgroup meetings

This article was originally published in The Gray Sheet

Executive Summary

Clinical Laboratory Improvement Advisory Committee Workgroup on Genetic Testing will discuss CLIA standards and requirements in relation to pre-analytic and post-analytic components of genetic testing at a May 27 meeting. The group will meet from 8:30 a.m.-5 p.m. and on May 28 from 8 a.m. to 10 a.m. at the Centers for Disease Control and Prevention in Atlanta. On May 28 from 10:30 a.m. to 5 p.m. and on May 29 from 8:30 a.m. to 5 p.m CLIAC will also present an update on CLIA implementation and review the amendments' relevance to assisted reproductive technology testing. Both meetings will be held in Auditorium B, Building 2. Comments are due by May 22. For more information, contact CDC's John Ridderhoff at 770/488-8076...

You may also be interested in...



HHS Policy Move Means FDA Must Publish More Documentation To Support Rulemaking Decisions

To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.

Dr Reddy's Strengthens Russian OTC Portfolio Through Glenmark Deal

Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.

Moderna Files COVID-19 Vaccine After Second Impressive Read-Out

Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel